Sirtuin 1 in Chronic Kidney Disease and Therapeutic Potential of Targeting Sirtuin 1

The incidence and prevalence of chronic kidney disease (CKD) continue to increase worldwide remaining as a major public health burden. CKD eventually progresses to end-stage kidney failure and patients with CKD have high morbidity and mortality. Sirtuin 1 (SIRT1), a NAD+-dependent deacetylases, has...

Descripción completa

Detalles Bibliográficos
Autores principales: Yan, Jiayi, Wang, Jue, He, John Cijiang, Zhong, Yifei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Endocrinology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9251114/
https://www.ncbi.nlm.nih.gov/pubmed/35795148
http://dx.doi.org/10.3389/fendo.2022.917773

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9251114/
https://www.ncbi.nlm.nih.gov/pubmed/35795148
http://dx.doi.org/10.3389/fendo.2022.917773

Ejemplares similares